nodes	percent_of_prediction	percent_of_DWPC	metapath
Diphemanil Methylsulfate—Tamoxifen—ABCC2—type 2 diabetes mellitus	0.00417	0.253	CrCbGaD
Diphemanil Methylsulfate—Tamoxifen—CYP2E1—type 2 diabetes mellitus	0.00293	0.178	CrCbGaD
Diphemanil Methylsulfate—Tamoxifen—CYP1A2—type 2 diabetes mellitus	0.00278	0.169	CrCbGaD
Diphemanil Methylsulfate—Ketoprofen—PTGS2—type 2 diabetes mellitus	0.00251	0.153	CrCbGaD
Diphemanil Methylsulfate—Ketoprofen—ALB—type 2 diabetes mellitus	0.00224	0.136	CrCbGaD
Diphemanil Methylsulfate—Tamoxifen—CYP3A4—type 2 diabetes mellitus	0.00184	0.112	CrCbGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—CALCA—type 2 diabetes mellitus	0.000616	0.000626	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR ligand binding—CCL2—type 2 diabetes mellitus	0.000614	0.000625	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	0.000605	0.000615	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	0.000603	0.000613	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—TLE4—type 2 diabetes mellitus	0.000588	0.000598	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—TLE4—type 2 diabetes mellitus	0.000587	0.000596	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—GLP1R—type 2 diabetes mellitus	0.000581	0.000591	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—GCG—type 2 diabetes mellitus	0.000572	0.000582	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—GCG—type 2 diabetes mellitus	0.00057	0.00058	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—ADRB3—type 2 diabetes mellitus	0.000566	0.000576	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—ADRB3—type 2 diabetes mellitus	0.000565	0.000574	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	0.000563	0.000572	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	0.000561	0.00057	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—CRHR1—type 2 diabetes mellitus	0.000547	0.000556	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—CRHR1—type 2 diabetes mellitus	0.000545	0.000554	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	0.000543	0.000552	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—SLC2A2—type 2 diabetes mellitus	0.000543	0.000552	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	0.000541	0.00055	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—AVP—type 2 diabetes mellitus	0.000536	0.000545	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—AVP—type 2 diabetes mellitus	0.000534	0.000543	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—CPT1A—type 2 diabetes mellitus	0.000532	0.000541	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—MTR—type 2 diabetes mellitus	0.000532	0.000541	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—NAMPT—type 2 diabetes mellitus	0.000521	0.00053	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—HBA1—type 2 diabetes mellitus	0.000518	0.000527	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—LIPC—type 2 diabetes mellitus	0.000518	0.000527	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—GCK—type 2 diabetes mellitus	0.000518	0.000527	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—CYP11A1—type 2 diabetes mellitus	0.000515	0.000524	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Circadian rythm related genes—IL6—type 2 diabetes mellitus	0.000512	0.000521	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	0.00051	0.000518	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	0.000508	0.000516	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—SLC9A1—type 2 diabetes mellitus	0.000506	0.000514	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	0.000505	0.000513	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	0.000503	0.000512	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	0.0005	0.000509	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—SPRY2—type 2 diabetes mellitus	0.0005	0.000509	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—CETP—type 2 diabetes mellitus	0.0005	0.000508	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	0.000499	0.000507	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—SPRY2—type 2 diabetes mellitus	0.000499	0.000507	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—GNB3—type 2 diabetes mellitus	0.000493	0.000501	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—GNB3—type 2 diabetes mellitus	0.000492	0.0005	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—RBP4—type 2 diabetes mellitus	0.000488	0.000496	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—GLP1R—type 2 diabetes mellitus	0.000488	0.000496	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—MMP3—type 2 diabetes mellitus	0.000486	0.000495	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—AVP—type 2 diabetes mellitus	0.000486	0.000495	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—RBP4—type 2 diabetes mellitus	0.000486	0.000494	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—GLP1R—type 2 diabetes mellitus	0.000486	0.000494	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 2 diabetes mellitus	0.000485	0.000494	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—AVP—type 2 diabetes mellitus	0.000485	0.000493	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—MMP3—type 2 diabetes mellitus	0.000485	0.000493	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	0.000484	0.000492	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 2 diabetes mellitus	0.000484	0.000492	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	0.000482	0.000491	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—CCKAR—type 2 diabetes mellitus	0.00048	0.000488	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—CCKAR—type 2 diabetes mellitus	0.000478	0.000486	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—PSMD6—type 2 diabetes mellitus	0.000465	0.000473	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—SREBF1—type 2 diabetes mellitus	0.000465	0.000473	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—SNAP25—type 2 diabetes mellitus	0.000465	0.000473	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—EDN1—type 2 diabetes mellitus	0.000463	0.00047	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—EDN1—type 2 diabetes mellitus	0.000461	0.000469	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—CTGF—type 2 diabetes mellitus	0.000456	0.000464	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	0.000456	0.000463	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	0.000454	0.000462	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—HMGCR—type 2 diabetes mellitus	0.000452	0.00046	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—C3—type 2 diabetes mellitus	0.000445	0.000453	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—C3—type 2 diabetes mellitus	0.000444	0.000451	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—ADRA2A—type 2 diabetes mellitus	0.000442	0.00045	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	0.00044	0.000447	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	0.000438	0.000445	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	0.000435	0.000442	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	0.000433	0.00044	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—IAPP—type 2 diabetes mellitus	0.000432	0.000439	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—IAPP—type 2 diabetes mellitus	0.000431	0.000438	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—INSR—type 2 diabetes mellitus	0.000429	0.000436	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—INSR—type 2 diabetes mellitus	0.000428	0.000435	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—CYP2E1—type 2 diabetes mellitus	0.000425	0.000432	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—AGT—type 2 diabetes mellitus	0.000423	0.00043	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	0.000422	0.000429	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—AGT—type 2 diabetes mellitus	0.000422	0.000429	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	0.000421	0.000428	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—TRPC6—type 2 diabetes mellitus	0.00042	0.000427	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—CYP1A2—type 2 diabetes mellitus	0.00042	0.000427	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—SLC2A1—type 2 diabetes mellitus	0.00042	0.000427	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	0.00042	0.000427	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	0.000419	0.000426	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—AGTR2—type 2 diabetes mellitus	0.000418	0.000425	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—CCR5—type 2 diabetes mellitus	0.000414	0.000421	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—CCR5—type 2 diabetes mellitus	0.000412	0.000419	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—CYP3A4—type 2 diabetes mellitus	0.00041	0.000417	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—C3—type 2 diabetes mellitus	0.000404	0.000411	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—C3—type 2 diabetes mellitus	0.000403	0.00041	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—GCG—type 2 diabetes mellitus	0.000403	0.00041	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—SLC2A4—type 2 diabetes mellitus	0.000403	0.00041	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	0.000402	0.000408	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—EDNRB—type 2 diabetes mellitus	0.0004	0.000407	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	0.000391	0.000397	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	0.00039	0.000396	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	0.00039	0.000396	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	0.00039	0.000396	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—PSMD6—type 2 diabetes mellitus	0.000389	0.000395	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—HTR2C—type 2 diabetes mellitus	0.000389	0.000395	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—AGT—type 2 diabetes mellitus	0.000384	0.000391	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—AGT—type 2 diabetes mellitus	0.000383	0.000389	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	0.000379	0.000386	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—EDNRA—type 2 diabetes mellitus	0.000378	0.000384	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	0.000378	0.000384	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—CYBA—type 2 diabetes mellitus	0.000378	0.000384	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—CALM1—type 2 diabetes mellitus	0.000376	0.000383	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—CYBA—type 2 diabetes mellitus	0.000376	0.000383	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	0.000371	0.000377	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	0.00037	0.000376	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—GHRL—type 2 diabetes mellitus	0.00037	0.000376	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—PLAT—type 2 diabetes mellitus	0.00037	0.000376	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—PLAT—type 2 diabetes mellitus	0.000368	0.000375	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—GHRL—type 2 diabetes mellitus	0.000368	0.000375	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—CALCA—type 2 diabetes mellitus	0.000365	0.000371	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—CALCA—type 2 diabetes mellitus	0.000364	0.00037	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	0.000355	0.000361	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	0.000354	0.00036	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—GNB3—type 2 diabetes mellitus	0.000347	0.000353	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—PPARGC1A—type 2 diabetes mellitus	0.000347	0.000353	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—HMOX1—type 2 diabetes mellitus	0.000346	0.000351	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	0.000344	0.00035	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	0.000343	0.000348	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	0.000342	0.000348	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	0.000341	0.000347	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—CAT—type 2 diabetes mellitus	0.000341	0.000347	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	0.000338	0.000344	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—GCG—type 2 diabetes mellitus	0.000338	0.000344	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—GCG—type 2 diabetes mellitus	0.000337	0.000343	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—PTPN1—type 2 diabetes mellitus	0.000337	0.000343	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	0.000333	0.000338	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	0.000331	0.000337	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	0.000331	0.000337	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—APOB—type 2 diabetes mellitus	0.000331	0.000337	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	0.00033	0.000336	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—GSTM1—type 2 diabetes mellitus	0.000322	0.000328	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	0.000316	0.000322	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—LPL—type 2 diabetes mellitus	0.000316	0.000321	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—CCL2—type 2 diabetes mellitus	0.000315	0.000321	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	0.000311	0.000316	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	0.00031	0.000316	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—AKT2—type 2 diabetes mellitus	0.00031	0.000315	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—ADCY5—type 2 diabetes mellitus	0.00031	0.000315	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	0.000309	0.000315	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—GPX1—type 2 diabetes mellitus	0.000308	0.000314	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—CD36—type 2 diabetes mellitus	0.0003	0.000305	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—PPP2CA—type 2 diabetes mellitus	0.000297	0.000302	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	0.000294	0.000299	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	0.000293	0.000298	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—GNB3—type 2 diabetes mellitus	0.000291	0.000296	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—GNB3—type 2 diabetes mellitus	0.00029	0.000295	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—MMP3—type 2 diabetes mellitus	0.000287	0.000292	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—AVP—type 2 diabetes mellitus	0.000287	0.000292	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—AVP—type 2 diabetes mellitus	0.000286	0.000291	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—MMP3—type 2 diabetes mellitus	0.000286	0.000291	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—IGF2—type 2 diabetes mellitus	0.000286	0.000291	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—IGF2—type 2 diabetes mellitus	0.000285	0.00029	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	0.000285	0.00029	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—MTHFR—type 2 diabetes mellitus	0.000285	0.000289	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	0.000284	0.000289	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	0.000282	0.000287	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	0.000281	0.000286	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—PPARA—type 2 diabetes mellitus	0.000279	0.000284	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—APOB—type 2 diabetes mellitus	0.000278	0.000282	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—APOB—type 2 diabetes mellitus	0.000277	0.000282	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	0.000277	0.000281	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—IGF1R—type 2 diabetes mellitus	0.000276	0.00028	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—EDN1—type 2 diabetes mellitus	0.000273	0.000278	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—EDN1—type 2 diabetes mellitus	0.000272	0.000277	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—AGT—type 2 diabetes mellitus	0.00027	0.000275	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—CALM1—type 2 diabetes mellitus	0.000266	0.00027	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—LPL—type 2 diabetes mellitus	0.000265	0.00027	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—APOE—type 2 diabetes mellitus	0.000265	0.000269	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—LPL—type 2 diabetes mellitus	0.000264	0.000269	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—APOA1—type 2 diabetes mellitus	0.000262	0.000266	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	0.00026	0.000264	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—ADCY5—type 2 diabetes mellitus	0.000259	0.000263	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	0.000249	0.000253	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	0.000248	0.000252	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—CCR5—type 2 diabetes mellitus	0.000244	0.000248	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—CCR5—type 2 diabetes mellitus	0.000244	0.000248	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—C3—type 2 diabetes mellitus	0.000239	0.000243	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—C3—type 2 diabetes mellitus	0.000238	0.000242	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—PPARG—type 2 diabetes mellitus	0.000231	0.000235	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	0.000228	0.000232	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—IRS2—type 2 diabetes mellitus	0.000227	0.000231	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—HIF1A—type 2 diabetes mellitus	0.000227	0.000231	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—AGT—type 2 diabetes mellitus	0.000227	0.000231	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—IRS2—type 2 diabetes mellitus	0.000226	0.00023	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—INS—type 2 diabetes mellitus	0.000226	0.00023	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—AGT—type 2 diabetes mellitus	0.000226	0.00023	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—CALM1—type 2 diabetes mellitus	0.000223	0.000227	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—CALM1—type 2 diabetes mellitus	0.000222	0.000226	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—LEP—type 2 diabetes mellitus	0.000222	0.000226	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—APOE—type 2 diabetes mellitus	0.000222	0.000226	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—LEP—type 2 diabetes mellitus	0.000222	0.000225	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—APOE—type 2 diabetes mellitus	0.000222	0.000225	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—APOA1—type 2 diabetes mellitus	0.00022	0.000223	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—APOA1—type 2 diabetes mellitus	0.000219	0.000223	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	0.00021	0.000213	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—PRKCB—type 2 diabetes mellitus	0.000209	0.000212	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—ALB—type 2 diabetes mellitus	0.000208	0.000211	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—PIK3R1—type 2 diabetes mellitus	0.000199	0.000202	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—NOS3—type 2 diabetes mellitus	0.000199	0.000202	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—IRS1—type 2 diabetes mellitus	0.000198	0.000202	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—IRS1—type 2 diabetes mellitus	0.000198	0.000201	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—INS—type 2 diabetes mellitus	0.00019	0.000193	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—INS—type 2 diabetes mellitus	0.000189	0.000192	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	0.000187	0.00019	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—CCL2—type 2 diabetes mellitus	0.000186	0.000189	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	0.000184	0.000187	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	0.000184	0.000187	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—IGF1—type 2 diabetes mellitus	0.000183	0.000186	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—AKT2—type 2 diabetes mellitus	0.000183	0.000186	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	0.000183	0.000186	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	0.000182	0.000185	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—PTGS2—type 2 diabetes mellitus	0.000182	0.000185	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	0.000174	0.000177	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	0.000174	0.000177	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	0.000167	0.000169	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	0.000167	0.000169	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	0.000166	0.000169	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—NOS3—type 2 diabetes mellitus	0.000166	0.000169	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	0.000157	0.000159	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—RELA—type 2 diabetes mellitus	0.000156	0.000159	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	0.000143	0.000145	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	0.000142	0.000145	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	0.000141	0.000144	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—CASP3—type 2 diabetes mellitus	0.000141	0.000143	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	0.00014	0.000143	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—IL6—type 2 diabetes mellitus	0.00014	0.000142	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	0.000134	0.000136	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—MMP9—type 2 diabetes mellitus	0.000133	0.000135	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	0.000132	0.000134	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	0.000132	0.000134	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	0.00013	0.000132	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	0.000129	0.000131	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	0.000123	0.000125	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—SRC—type 2 diabetes mellitus	0.000123	0.000125	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	0.00012	0.000122	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	0.00012	0.000122	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	0.00011	0.000112	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	0.00011	0.000112	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	0.000108	0.00011	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—EGFR—type 2 diabetes mellitus	0.000108	0.000109	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—AKT1—type 2 diabetes mellitus	9.13e-05	9.28e-05	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	8.3e-05	8.44e-05	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—IL6—type 2 diabetes mellitus	8.27e-05	8.41e-05	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.66e-05	7.78e-05	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.63e-05	7.76e-05	CbGpPWpGaD
